Background: Concomitant evaluation of the metabolic and growth-promoting effects of growth hormone (GH) therapy in Turner syndrome (TS) may be used in the prediction of the growth response to GH therapy.
Aim: To evaluate the metabolic effects of GH therapy in TS and correlation with the short-term growth response.
Patients: 24 prepubertal children with TS, aged 9.